60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released Nov 13, 2025, during market hours
10-Q filed Nov 13, 2025, 44 days after period end · 0001554855-25-002032
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $437.60K | $135.29K | $51.19K | $168.19K |
| Net Income | -$2.32M | -$2.16M | $4.18M | -$1.45M |
| EPS Diluted | -$2.66 |
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
| -$2.92 |
| $9.13 |
| -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.